Literature DB >> 10337013

Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.

F Obermeier1, G Kojouharoff, W Hans, J Schölmerich, V Gross, W Falk.   

Abstract

Excess nitric oxide formation caused by the activity of the inducible nitric oxide synthase has been implicated as a toxic effector molecule in the pathogenesis of experimental colitis and inflammatory bowel disease. It was therefore investigated whether inhibition of this synthase or the cytokines TNF and IFN-gamma, inducers of nitric oxide synthase, had effects on chronic colitis in mice. Chronic colitis was induced in mice by repeated feeding of DSS. Cytokines were neutralized by treatment with MoAbs and nitric oxide synthase was inhibited by aminoguanidine. The degree of colonic inflammation was assessed by a histological score and colon length. Aminoguanidine treatment reduced nitric oxide activity by 60% (P = 0. 0004), the histological score by 31% (P = 0.005) and increased colon length by 1.4 cm (P = 0.002). Neutralization of TNF and IFN-gamma resulted in increased colon length (0.7 cm, P = 0.07 and 0.8 cm, P = 0.03), improved histological score (19%, P = 0.045 and 25%, P = 0. 013), and reduced nitric oxide activity (31%, P = 0.07 and 54%, P = 0.004) compared with controls. The combination of anti-cytokine treatments had additive effects. TNF and IFN-gamma are involved in perpetuation of chronic DSS-induced colitis, and induction of excessive nitric oxide activity could be their common effector mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337013      PMCID: PMC1905281          DOI: 10.1046/j.1365-2249.1999.00878.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  79 in total

1.  Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.

Authors:  S J McKenzie; M S Baker; G D Buffinton; W F Doe
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 2.  Nitrite from inflammatory cells--a cancer risk factor in ulcerative colitis?

Authors:  W E Roediger; M J Lawson; B C Radcliffe
Journal:  Dis Colon Rectum       Date:  1990-12       Impact factor: 4.585

3.  Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.

Authors:  T I Roach; C H Barton; D Chatterjee; F Y Liew; J M Blackwell
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

4.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis.

Authors:  M J Miller; J H Thompson; X J Zhang; H Sadowska-Krowicka; J L Kakkis; U K Munshi; M Sandoval; J L Rossi; S Eloby-Childress; J S Beckman
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

6.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

Authors:  R T Gazzinelli; I Eltoum; T A Wynn; A Sher
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  CD4+ intestinal mucosal lymphocytes in the pathogenesis of Crohn's disease.

Authors:  M Watanabe; H Takaishi; Y Hosoda; T Ezaki; T Yajima; N Inoue; Y Ueno; Y Iwao; H Ishii; H Ishikawa
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

8.  A fluorometric assay for the measurement of nitrite in biological samples.

Authors:  T P Misko; R J Schilling; D Salvemini; W M Moore; M G Currie
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

9.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  Potential role of nitric oxide in a model of chronic colitis in rhesus macaques.

Authors:  K A Ribbons; X J Zhang; J H Thompson; S S Greenberg; W M Moore; C M Kornmeier; M G Currie; N Lerche; J Blanchard; D A Clark
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

View more
  126 in total

1.  IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1β.

Authors:  Louise E Glover; Karina Irizarry; Melanie Scully; Eric L Campbell; Brittelle E Bowers; Carol M Aherne; Douglas J Kominsky; Christopher F MacManus; Sean P Colgan
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

2.  Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport.

Authors:  Gisela Paul; Ronald R Marchelletta; Declan F McCole; Kim E Barrett
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

3.  Resveratrol suppresses colitis and colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Anne B Hofseth; Edsel Pena; Joshua Habiger; Alexander Chumanevich; Deepak Poudyal; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

4.  Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation.

Authors:  Christian F Krieglstein; Christoph Anthoni; Wolfgang H Cerwinka; Karen Y Stokes; Janice Russell; Matthew B Grisham; D Neil Granger
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

5.  Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis.

Authors:  Christian F Krieglstein; Wolfgang H Cerwinka; Andrew G Sprague; F Stephen Laroux; Matthew B Grisham; Victor E Koteliansky; Norbert Senninger; D Neil Granger; Antonin R de Fougerolles
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

6.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

7.  PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.

Authors:  M R Spalinger; S Kasper; C Chassard; T Raselli; I Frey-Wagner; C Gottier; S Lang; K Atrott; S R Vavricka; F Mair; B Becher; C Lacroix; M Fried; G Rogler; M Scharl
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

8.  Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Authors:  Isabella Rauch; Felix Rosebrock; Eva Hainzl; Susanne Heider; Andrea Majoros; Sebastian Wienerroither; Birgit Strobl; Silvia Stockinger; Lukas Kenner; Mathias Müller; Thomas Decker
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

9.  Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents.

Authors:  Tania Marchbank; Asif Mahmood; Anthony J Fitzgerald; Jan Domin; Matt Butler; Robert A Goodlad; George Elia; Helen M Cox; David A van Heel; Subrata Ghosh; Raymond J Playford
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

10.  Interleukin-33 exacerbates acute colitis via interleukin-4 in mice.

Authors:  Peter N Pushparaj; Dong Li; Mousa Komai-Koma; Rodrigo Guabiraba; James Alexander; Charles McSharry; Damo Xu
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.